EICKELMANN, Peter P,MARK, Michael M,SEMAN, Leo John LJ,THOMAS, Leo L,BROEDL, Uli U,GREMPLER, Rolf R,‧艾克爾曼,‧馬克,‧西曼,‧托馬斯,‧布羅德爾,‧格雷姆普勒
申请号：
HK16101977.7
公开号：
HK1213820A
申请日:
2012.02.22
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions
